Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1435)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3390)
  2. Solid Tumor Oncology Division (3390)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (636)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (110)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (702)
  2. Journal of Thoracic Oncology (515)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (781)
  2. Elsevier Inc. (736)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3390)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A
    Journal Article

    Talbot, S. G.; O-Charoenrat, P.; Sarkaria, I. S.; Ghossein, R.; Reddy, P.; Ngai, I.; Cordeiro, C. N.; Wong, R. J.; Kris, M. G.; Rusch, V. W.; more...
    Annals of Surgical Oncology (2004)

    Fulltext@MSK | Save
  • Phase I and pharmacokinetic study of the novel oral cell-cycle inhibitor Ro 31-7453 in patients with advanced solid tumors
    Journal Article

    Dupont, J.; Bienvenu, B.; Aghajanian, C.; Pezzulli, S.; Sabbatini, P.; Vongphrachanh, P.; Chang, C.; Perkell, C.; Ng, K.; Passe, S.; more...
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas of the lung
    Meeting Abstract

    Talbot, S. G.; Sarkaria, I. S.; Maghami, E.; O-Charoenrat, P.; Estilo, C.; Socci, N. D.; Ngai, I.; Ghossein, R. A.; Kris, M. G.; Rusch, V. W.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Pulsatile administration of the EGF receptor inhibitor Iressa (ZD1839) is significantly more effective than continuous dosing for sensitizing tumors to taxol
    Meeting Abstract

    Solit, D. B.; She, Y.; Moasser, M. M.; Hudis, C. A.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer
    Meeting Abstract

    Rosenzweig, K. E.; Yorke, E.; Jackson, A.; Nayak, R.; Rusch, V. W.; Kris, M. G.; Fuks, Z.; Ling, C. C.; Leibel, S. A.
    International Journal of Radiation Oncology, Biology, Physics (2003)

    Fulltext@MSK | Save
  • The epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib (TarcevaTM, OSI-774), is an active agent in bronchioloalveolar carcinoma (BAC) and its variants: Interim results of a phase II trial
    Meeting Abstract

    Patel, J.; Miller, V.; Kris, M.; Shah, N.; Tyson, L.; Pizzo, B.; Zakowski, M.; Cespon, M.; Heelan, R.; Johnson, D.
    EJC Supplements (2003)

    Fulltext@MSK | Save
  • Antigen expression on small cell lung cancer (SCLC) cell lines confirms selection of a tetravalent vaccine against SCLC containing GM2, fucosyl GM1, globo H and polysialic acid
    Meeting Abstract

    Livingston, P. O.; Hood, C.; Krug, L.; Kris, M. G.; Ragupathi, G.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Pulsatile administration of the EGF receptor inhibitor gefitinib (Iressa, ZD 1839) is significantly more effective than continuous dosing for sensitizing tumors to Taxol
    Meeting Abstract

    Solit, D. B.; She, Y.; Moasser, M.; Hudis, C.; Kris, M.; Scher, H.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Phase 1 study of 10-propargyl-10-deazaaminopterin (PDX) plus docetaxel or paclitaxel in patients with advanced cancer
    Meeting Abstract

    Azzoli, C. G.; Krug, L. M.; Miller, V. A.; Sharma, S.; Gomez, J.; Kris, M. G.; Ginsberg, M.; Baez, V.; Henry, R.; Tyson, L.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • The Basche/Kelly article reviewed [Treatment of non-small-cell lung cancer in older persons]
    Journal Article

    Hurria, A.; Kris, M.
    Oncology (Norwalk) (2003)

    Fulltext@MSK | Save